Predictors of invasive versus conservative treatment in elderly patients with acute coronary syndromes.

Original title: Predictors of Treatment in Acute Coronary Syndromes in the Elderly: Impact on Decision Making and Clinical Outcome After Interventional Versus Conservative Treatment. Reference: Harald Rittger et al. Catheterization and Cardiovascular Interventions 80:735–743 (2012).

This study, recently published in Cath Cardiovasc Interven, was performed to determine the factors that helped physicians decide to be conservative or invasive. Were analyzed retrospectively 1,001 consecutive patients over 75 years who were admitted for acute coronary syndromes with or without ST segment elevation (NSTACS or STACS).

The decision to perform catheterization and eventually an angioplasty or coronary artery bypass graft surgery was at the discretion of the treating physicians. Out of the patients analyzed, 754 (76%) were admitted for SCANST and 776 (77.5%) received an invasive strategy. An analysis was performed by logistic regression for multiple baseline characteristics and in that way potential intricacies were identified.

Predictors for a conservative strategy were:

  • Advanced age (the most powerful)
  • Killip III functional class
  • three-vessel injury
  • Prior stroke
  • Obesity
  • Previous renal failure
  • Type of acute coronary syndrome
  • Previous infarction
  • The presence of supraventricular arrhythmias.

Mortality from all causes in patients treated conservatively was 15.6% versus 3.5% of patients treated invasively, which is significantly in favor of an invasive strategy (p <0.001). The authors refer to an important limitation of the study: it is a retrospective analysis of a single center. However, the fact that patients are consecutive shows the reality of clinical practice beyond the trials and records for this age group.

Conclusion 

In this analysis, older age was the strongest predictor for a conservative approach. Other features that are associated with increased clinical risk also tipped the balance towards conservative treatment.

Editorial comment

The management of elderly patients with acute coronary syndromes has not been standardized, given the lack of evidence coming from randomized and multicenter studies. The recommendations of the guidelines have been made mostly by transferring the results of studies in much younger patients, which often leaves older patients in the hands of its natural evolution, mainly from fear of medical complications.

These complications are, of course, more frequent in elderly patients but in no way counterbalance the potential benefit of an invasive strategy over total mortality rates. The proportion of elderly patients entering our hospitals is increasing, (and still growing), so this dilemma will become more common in all coronary care units. 

Finally, we should bear in mind that we probably never have sufficient information from randomized and multicenter works designed specifically for elderly patients.

SOLACI.ORG

More articles by this author

DAPT ≤30 Days After Drug-Coated Balloon Coronary Angioplasty

Drug-coated balloon (DCB) coronary angioplasty without stent implantation has become a well-established alternative in several clinical scenarios, particularly in patients at high bleeding risk...

Is IVUS Always Necessary for Left Main Coronary Artery PCI?

Percutaneous coronary intervention (PCI) of the unprotected left main coronary artery is a highly complex procedure because of the large amount of myocardium at...

Dual-Prep Registry: Atherectomy and IVL for Severe Coronary Calcification

Severe coronary calcification remains one of the most challenging scenarios in percutaneous coronary intervention (PCI). Although rotational or orbital atherectomy and intravascular lithotripsy (IVL)...

Prehospital heparin in STEMI: A safe strategy associated with improved early reperfusion

Early reperfusion remains the main prognostic determinant in patients with ST-segment elevation myocardial infarction (STEMI). Although primary percutaneous coronary intervention (PCI) is the treatment...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Redo-TAVI with SAPIEN 3: 30-Day Outcomes

The indications for transcatheter aortic valve implantation (TAVI) have rapidly expanded to include intermediate- and low-risk patients, extending its use to younger individuals with...

DAPT ≤30 Days After Drug-Coated Balloon Coronary Angioplasty

Drug-coated balloon (DCB) coronary angioplasty without stent implantation has become a well-established alternative in several clinical scenarios, particularly in patients at high bleeding risk...

Coronary artery disease progression after transcatheter aortic valve replacement: quantitative coronary angiography and Quantitative Flow Ratio analysis

The coexistence of coronary artery disease and severe aortic stenosis is common among patients undergoing transcatheter aortic valve replacement (TAVR). However, the impact of...